Clinical Trial: Effect of the Peripheral κ-Opioid Receptor Agonist Anruikfen on Postoperative Recovery Quality in Patients Undergoing Gynecological Laparoscopic Surgery: A Clinical Study Based on the Enhanced Recovery After Surgery (ERAS) Concept (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of the Peripheral κ-Opioid Receptor Agonist Anruikfen on Postoperative Recovery Quality in Patients Undergoing Gynecological Laparoscopic Surgery: A Clinical Study Based on the Enhanced Recovery After Surgery (ERAS) Concept'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130513

Registration Time: 2026/08/20

Type: Interventional study

Primary Sponsor: Yijishan Hospital of Wannan Medical college

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339304

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Effect of the Peripheral κ-Opioid Receptor Agonist Anruikfen on Postoperative Recovery Quality in Patients Undergoing Gynecological Laparoscopic Surgery: A Clinical Study Based on the Enhanced Recovery After Surgery (ERAS) Concept (China)